Your browser doesn't support javascript.
loading
Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.
Sweere, Johanna M; Van Belleghem, Jonas D; Ishak, Heather; Bach, Michelle S; Popescu, Medeea; Sunkari, Vivekananda; Kaber, Gernot; Manasherob, Robert; Suh, Gina A; Cao, Xiou; de Vries, Christiaan R; Lam, Dung N; Marshall, Payton L; Birukova, Maria; Katznelson, Ethan; Lazzareschi, Daniel V; Balaji, Swathi; Keswani, Sundeep G; Hawn, Thomas R; Secor, Patrick R; Bollyky, Paul L.
Afiliação
  • Sweere JM; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Van Belleghem JD; Stanford Immunology, Stanford University, Stanford, CA, USA.
  • Ishak H; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Bach MS; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Popescu M; Palo Alto Veterans Institute of Research, Palo Alto, CA, USA.
  • Sunkari V; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Kaber G; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Manasherob R; Stanford Immunology, Stanford University, Stanford, CA, USA.
  • Suh GA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Cao X; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • de Vries CR; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Lam DN; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Marshall PL; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Birukova M; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Katznelson E; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Lazzareschi DV; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Balaji S; Stanford Immunology, Stanford University, Stanford, CA, USA.
  • Keswani SG; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Hawn TR; Stanford Immunology, Stanford University, Stanford, CA, USA.
  • Secor PR; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Bollyky PL; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
Science ; 363(6434)2019 03 29.
Article em En | MEDLINE | ID: mdl-30923196
ABSTRACT
Bacteriophage are abundant at sites of bacterial infection, but their effects on mammalian hosts are unclear. We have identified pathogenic roles for filamentous Pf bacteriophage produced by Pseudomonas aeruginosa (Pa) in suppression of immunity against bacterial infection. Pf promote Pa wound infection in mice and are associated with chronic human Pa wound infections. Murine and human leukocytes endocytose Pf, and internalization of this single-stranded DNA virus results in phage RNA production. This triggers Toll-like receptor 3 (TLR3)- and TIR domain-containing adapter-inducing interferon-ß (TRIF)-dependent type I interferon production, inhibition of tumor necrosis factor (TNF), and the suppression of phagocytosis. Conversely, immunization of mice against Pf prevents Pa wound infection. Thus, Pf triggers maladaptive innate viral pattern-recognition responses, which impair bacterial clearance. Vaccination against phage virions represents a potential strategy to prevent bacterial infection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fagocitose / Pseudomonas aeruginosa / Infecções por Pseudomonas / Infecção dos Ferimentos / Fagos de Pseudomonas / Tolerância Imunológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fagocitose / Pseudomonas aeruginosa / Infecções por Pseudomonas / Infecção dos Ferimentos / Fagos de Pseudomonas / Tolerância Imunológica Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article